Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
about
Tissue engineering for bone regeneration and osseointegration in the oral cavityCTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.Rescue of splicing-mediated intron loss maximizes expression in lentiviral vectors containing the human ubiquitin C promoter.UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors.A future for transgenic livestock.Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.HIV-1 Is Restricted prior to Integration of Viral DNA in Primary Cord-Derived Human CD34+ Cells.Current status and prospects for gene therapy.Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Hematopoietic stem cell gene therapy with drug resistance genes: an update.Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis.Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.Targeting lentiviral vectors to antigen-specific immunoglobulins.Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule.Lentiviral vectors for immune cells targeting.Gene therapy: progress in childhood disease.Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells.Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration.Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies.Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA.Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesisLentiviral transduction of neuronal cells.Bone formation in rabbit's leg muscle after autologous transplantation of bone marrow-derived mesenchymal stem cells expressing human bone morphogenic protein-2Osteogenic differentiation of human periodontal ligament cells after transfection with recombinant lentiviral vector containing follicular dendritic cell secreted protein.Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection.Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates.Transfection with follicular dendritic cell secreted protein to affect phenotype expression of human periodontal ligament cells.Multimodality reporter gene imaging: Construction strategies and application.
P2860
Q28087194-2508051D-6563-4783-9375-0F93ED6E5B79Q33713346-BBF4CB61-4DB4-45B6-9632-7F8CAD9106B9Q33843471-76E360C7-668C-4B94-ADAC-CA0761F73012Q34883547-5A654672-292D-4088-9FC9-24F517CEA5FAQ35515230-46CAE772-B7FD-4DCE-88F1-CAE9CAD62E65Q35550198-FEAA2FD5-080B-4530-9BEC-28BAB4639175Q35847830-EE6D84DD-6970-4193-A52C-1416FBE5E29CQ35861171-E8422BB2-BDA0-4BC4-9497-B655482B860FQ35881934-846058D3-69A2-4EEA-A543-5E10B6D971E5Q35904439-674130A3-D35A-43A2-AA49-28CD8B7181A5Q35973411-4DD61360-1957-47A4-B9C4-DD0D55FEC0D5Q36204222-B4D82AE9-2A3F-4A53-ACC1-1167992F6B45Q36248825-35F04C81-020A-4DFF-A349-8E1DA0C11E12Q36288888-76B97631-F2DF-4F69-B0A8-28DF417A866AQ36673678-9C0BB775-E02A-4876-8330-1E91ECD7C4ADQ36828170-023D6EBF-7096-40D8-8984-02E7488B1AD2Q37008067-FC727153-56C0-48F7-9750-F2E9439D4B84Q37276857-C193FB16-DE45-4755-8D62-591EB919BAEBQ37677792-C1FD2884-B618-4A26-A0C6-E785DE9FFBC9Q37948091-6F285BB1-BF19-4F38-8397-84F6C90B25DEQ38721413-05ED8BF8-E4BC-4E93-B2C1-958164ECB9A2Q38797204-104D88C0-5B51-4A44-AB2A-8A162FB773C5Q38905682-60D86D72-3869-49FC-B794-774E904EE736Q40005186-914515FE-2572-4571-90E2-95AE6D0B5CF2Q40545305-5FBD9F07-1E87-4CAA-86DA-FDD03647DC66Q40698841-D99C0C17-EBEC-4699-BEAB-7FF83E76F405Q42045025-6A453A62-46A3-4308-9126-F239A3863F31Q42261436-5AAE84A4-3693-4E97-8981-3E8B7D91B2E9Q45000795-50B30EAE-2E05-4EA2-BF57-4E77D919A4FBQ45861533-C1D2470C-B3DE-40A3-905E-DD601CA05433Q50482028-C4BFBD29-B40F-4AC6-8DF3-805E4C3D7A8BQ55046163-E2057D85-C520-4BA7-93BE-BEA23ECF3DDA
P2860
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@ast
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@en
type
label
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@ast
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@en
prefLabel
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@ast
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
@en
P1476
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells
@en
P2093
Carolyn Lutzko
P304
P356
10.1016/S0958-1669(02)00346-4
P577
2002-10-01T00:00:00Z